niveaux

Carmat is the first auto-regulating, bioprosthetic artificial heart, able to mimic the natural physiology of the human heart like never before.

INVESTORS

Here you will find comprehensive details and documentation for investors, analysts and individual shareholders.

Learn more

We are now on the verge of a
new stage in Carmat development, which we are approaching with enthusiasm and confidence as we seek to expand in the international market.

Stéphane Piat
Carmat CEO
author
Share price
FINANCIAL CALENDAR
September 28th 2018
Half-year financial results
April 5th 2018
Shareholders' Meeting
February 13th 2018
2017 Full-Year Results
>> Go to Calendar
DOCUMENTATION
  • document
    Document de référence 2017 - English...
    Download
  • document
    Half-yearly financial report 2014
    Download
>> Access to the regulated information

Journalists

Carmat news, updates and events: all the latest information about the company.

Learn more

Press contact:

contact

Caroline Carmagnol

ALIZE RP

LATEST NEWS

CARMAT: Continuing progress in line with the objective of obtaining CE marking in 2019

>> Go to news